ALEXANDRIA, Va., July 30 -- United States Patent no. 12,370,153, issued on July 29, was assigned to INFORLIFE SA (Campascio, Switzerland).
"Ready-to-use ketamine premix formulation" was invented by Sergio Dusci (Tresivio, Italy).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a sterile, ready-to-use, stable aqueous solution of ketamine suitable for direct intravenous infusion to a patient in need thereof, wherein the composition is disposed within a sealed infusion container as a premixture. The invention further relates to aqueous solutions of ketamine that are free of antimicrobials such as benzethonium chloride and are shelf-stable. The pharmaceutical compositions can be used, for e...